Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis

References

• Prattm AG, Isaacs JD, Mattey DL. Current concepts in the pathogenesis of early rheumatoid arthritis. Best Pract Res Clin Rhematol. 2009; 23:37–48.
   PubMedGoogle Scholar
• Myew-Ling T, Pierre M. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr Opin Rhematol. 2007; 19:284–288.
   PubMed Web of Science ®Google Scholar
• Van Vollenhoven RF. Treatment of rheumatoid arthritis: state of the art. Nat Rev Rhematol. 2009; 5:531–541.
   PubMed Web of Science ®Google Scholar
• Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006; 54:26–37.
   PubMed Web of Science ®Google Scholar
• Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet. 2008; 372:375–382.
   PubMed Web of Science ®Google Scholar
• Oukka M. Th17 cells in immunity and autoimmunity. Ann Rheum Dis. 2008; 67 Suppl III: iii26–iii29.
   PubMedGoogle Scholar
• van Eden W. Stress proteins as targets for anti-inflammatory therapies. Drug Discovery Today. 2000; 5:115–120.
   PubMed Web of Science ®Google Scholar
• Cohen IR, Young DB. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today. 1991; 12:105–110.
   PubMedGoogle Scholar
• van Eden W, Thole JER, van der Zee R, Noordzij A, Van Embden JDA, Hensen EJ, Cohen IR. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988; 331:171–173.
   PubMed Web of Science ®Google Scholar
• Alberta GA, van der Zee R, Taams LS, van Eden W. A self-Hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis. Inter Immmunol. 2000; 12:1041–1050.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Cohen IR. Heat shock proteins as endogenous adjuvant in sterile and septic inflammation. J Immunol. 2005; 175:2777–2782.
   PubMed Web of Science ®Google Scholar
• Katsara M, Minigo G, Plebanski M, Apostolopoulos V. The good, the bad and the ugly: how altered peptide ligands modulate immunity. Exp Opin Biol Ther. 2008; 8:1873–1884.
   PubMed Web of Science ®Google Scholar
• Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, . Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, Based on the immunodominant type 1 diabetes autoantigen insulin BChain (9–23) peptide. Diabetes. 2000; 51:2126–2134.
   Web of Science ®Google Scholar
• Aruna BV, Sela M, Mozes E. Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells. PNAS. 2005; 102:10285–10290.
   PubMed Web of Science ®Google Scholar
• Alberta Paul GA, van Kooten PJS, van Eden W, van der Zee R. Highly Autoproliferative T cells specific for 60-kda heat shock protein produce IL-4/IL-10 and IFN-g and are protective in adjuvant arthritis. J Immunol. 2000; 165:7270–7277.
   PubMed Web of Science ®Google Scholar
• Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 2001; 103:407–416.
   PubMed Web of Science ®Google Scholar
• Domínguez MC, Lorenzo N, Barberá A, Darrasse-Jeze G, Hernández MV, Torres AM, Hernández I, Gil R, Klatzmann D, Garay H, Reyes O, Padrón G. An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant induced arthritis. Autoimmunity. 20111–12 Early Online.
   Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:315–324.
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GPS. ProPred: Prediction of HLA-DR binding sites. Bioinformatics. 2001; 17:1236–1237.
   PubMed Web of Science ®Google Scholar
• De Magistris MT, Alexander J, Coggeshall M, altman A, Gaeta FCA, Grey HM, Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992; 68:625–634.
   PubMed Web of Science ®Google Scholar
• Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T cell anergy by altered T-cell-receptor ligand on live antigen-presenting cell. Nature. 1993; 363:156–159.
   PubMed Web of Science ®Google Scholar
• Racioppi L, Ronchese F, Matis LA, Germain RN. Peptide major histocompatibility complex class II complexes with mixed agonist-antagonist properties provide evidence for ligand differences in T cell receptor-dependent intracellular signaling. J Exp Med. 1993; 177:1047–1060.
   PubMed Web of Science ®Google Scholar
• Anderton SM. Ppetide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunol. 2001; 104:367–376.
   PubMed Web of Science ®Google Scholar
• Peakman M, Dayan CM. Antigen-specific immunotherapy for autoimmune diseases: fighting with fire and fire?. Immunol. 2001; 104:361–366.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Cohen IR. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide'accelerated diabetes. J Immunol. 2002; 169:6030–6035.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Mor F, Cohen IR. DNA fragments of human HSP60 vaccinate againts adjuvant arthritis: Identification of s regulatory HSP60 peptide. J Immunol. 2003; 171:3533–3541.
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Mimran A, Carmi P, Mor F, Cohen IR. HSP60 as a target of anti-ergotypic regulatory T cells. PloS ONE. 2008; 3:4026–4036.
   PubMed Web of Science ®Google Scholar
• Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage. Nature Medicine. 2007; 13:139–145.
   PubMed Web of Science ®Google Scholar
• O' Garra A, Viera P. Th1 cells control themselves by producing interleukin-10. Nature Rev. 2007; 7:425–428.
   Web of Science ®Google Scholar
• Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, Gordon G, . Tolerogenic immune response to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet. 2005; 366:50–56.
   PubMed Web of Science ®Google Scholar
• Jong H, Lafeber F, Jager1 W, Haverkamp MH, Kuis W, Bijlsma JW, Prakken BJ, Albani S. PAN-DR-Binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis. Arthritis Rheumat. 2009; 60:1966–1976.
   PubMedGoogle Scholar
• Bielekova B, Martin R. Antigen-specific immunomodulation via altered peptide ligands. J Mol Med. 2001; 79:552–565.
   PubMed Web of Science ®Google Scholar
• Guan P, Doytchinova IA, Zygouri C, Flower DR. MHCPred: A server for quantitative prediction of peptide-MHC binding. Nucl Acids Res. 2003; 31:3621–3624.
   PubMed Web of Science ®Google Scholar
• Li R, Li X, Li P, Yao ZQ, Guo JL, Li ZG. Effect of multiple amino acid substitutions of collagen II 263–272 on collagen-induced arthritis. Beijing Da Xue Xue Bao. 2006; 38:360–364.
   PubMedGoogle Scholar
• Yao ZQ, Li R, Li ZG. A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis. Ann Rheum Dis.. 2007; 66:423–424.
   PubMed Web of Science ®Google Scholar
• Reche PA, Glutting JP, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide biding to MHCmolecules using profiles. Immunogenetics. 2004; 56:405–419.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Hilder K, Becker C, Schalaak JF, Barbulescu K, Germann T, . Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): mechanism for methotrexate-mediated immunosupression. Clin Exp Immunol. 1999; 115:42–55.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, . A distinct lineage of CD4 T cells regulate tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6:1133–1141.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, . Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999; 42:963–970.
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-Deficient Mice. J Immunol. 2003; 171:6173–6177.
   PubMed Web of Science ®Google Scholar
• Kinder AJ, Hassell AB, Brand J, Brownfield AM, Grove M, Shadforth MF. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology. 2005; 44:61–66.
   PubMed Web of Science ®Google Scholar